作为潜在的光敏化剂,易于合成化胺
Éva Bakos1, Henrietta Ágoston2, Rebeka Ignácz2,3
1Drug Resistance Research Group, Institute of Molecular Life Sciences, Research Centre for Natural Sciences, Hungarian Research Network, Magyar Tudósok Körútja 2, H-1117 Budapest, Hungary.
International journal of molecular sciences
|February 26, 2025
概括
研究人员开发了一种微波辅助合成的新色素染料. 这些基胺化合物对皮肤癌细胞表现出强烈的光诱导毒性,其中一种衍生物显示出光动力学治疗的巨大潜力.
科学领域:
- 有机化学 有机化学
- 药用化学 医学化学
- 摄影化学的使用.
背景情况:
- 胺染料,一种类型的丁染料,具有优良的光物理性质,使它们适合各种应用.
- 由于其有效性,它们在光动力学疗法 (PDT) 中作为光敏化剂的潜力正在获得显著的关注.
- 光动力疗法是一种使用光激活药物杀死癌细胞的治疗方式.
研究的目的:
- 报告一种简单而有效的微波辅助新型胺染料的合成.
- 为了评估合成的基胺衍生物对A431人类表皮癌细胞系的细胞毒性作用.
- 评估这些化合物作为光动力学疗法的光敏化剂的潜力,特别是对于皮肤癌.
主要方法:
- 微波辅助合成,涉及化衍生物与1,3-二甲基亚胺醇或8-基朱洛利丁在烯中的反应.
- 对由此产生的化胺化合物对A431人类表皮癌细胞系的细胞毒性作用的研究.
- 评估光诱导毒性和计算光毒性指数,以确定光敏剂的有效性.
主要成果:
- 合成产生了新型的pyridyl rozamine染料,有效地使用微波辐射.
- 合成的化合物对A431细胞表现出显著的光诱导细胞毒性,在亚微分子到低纳米分子范围内观察到效应.
- 一种基于朱洛利丁的衍生品呈现出超过100的光毒性指数,这表明光诱导的疗效比黑暗毒性增加了两个数量级.
结论:
- 开发的微波辅助方法提供了一条高效的途径,以获得新型化胺染料.
- 这些胺衍生物在光动力疗法中表现出有前途的光敏化活性.
- 这种基于朱洛利丁的衍生物是开发用于皮肤癌光动力疗法的新光敏剂的强有力的候选者.
相关概念视频
Cycloaddition Reactions: MO Requirements for Photochemical Activation
2.0K
Some cycloaddition reactions are activated by heat, while others are initiated by light. For example, a [2 + 2] cycloaddition between two ethylene molecules occurs only in the presence of light. It is photochemically allowed but thermally forbidden.
2.0K
Photochemical Electrocyclic Reactions: Stereochemistry
1.8K
The absorption of UV–visible light by conjugated systems causes the promotion of an electron from the ground state to the excited state. Consequently, photochemical electrocyclic reactions proceed via the excited-state HOMO rather than the ground-state HOMO. Since the ground- and excited-state HOMOs have different symmetries, the stereochemical outcome of electrocyclic reactions depends on the mode of activation; i.e., thermal or photochemical.
Selection Rules: Photochemical Activation
Selection Rules: Photochemical Activation
1.8K
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
2.9K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
2.9K
Diazonium Group Substitution with Halogens and Cyanide: Sandmeyer and Schiemann Reactions
1.8K
Arenediazonium substitution reactions occur when the diazonium group is substituted by various functional groups such as halides, hydroxyl, nitrile, etc. For instance, arenediazonium salts react with copper(I) salts of chloride, bromide, or cyanide to form corresponding aryl chlorides, bromides, and nitriles. These reactions are named Sandmeyer reactions. Although the mechanism of this reaction is complicated, as illustrated in Figure 1, they are believed to progress via an aryl copper...
1.8K
Nucleophilic Aromatic Substitution of Aryldiazonium Salts: Aromatic SN1
2.1K
Treating arylamines with nitrous acid gives aryldiazonium salts that are effective substrates in nucleophilic aromatic substitution reactions. The diazonio group in these salts can be easily displaced by different nucleophiles, yielding a wide variety of substituted benzenes. The leaving group departs as nitrogen gas, and this easy elimination is the driving force for the substitution reaction.
In the Sandmeyer reaction, for example, the diazonio group is replaced by a chloro, bromo,...
In the Sandmeyer reaction, for example, the diazonio group is replaced by a chloro, bromo,...
2.1K
![Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60786.jpg&w=3840&q=50)
![[DPEPhosbcpCu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59739.jpg&w=3840&q=50)
